Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 334

1.

Phosphorylation of beta-catenin by cyclic AMP-dependent protein kinase.

Taurin S, Sandbo N, Qin Y, Browning D, Dulin NO.

J Biol Chem. 2006 Apr 14;281(15):9971-6. Epub 2006 Feb 13.

2.
3.

Substitution of a glycogen synthase kinase-3beta phosphorylation site in presenilin 1 separates presenilin function from beta-catenin signaling.

Kirschenbaum F, Hsu SC, Cordell B, McCarthy JV.

J Biol Chem. 2001 Mar 9;276(10):7366-75. Epub 2000 Dec 4.

4.

A GSK3beta phosphorylation site in axin modulates interaction with beta-catenin and Tcf-mediated gene expression.

Jho Eh, Lomvardas S, Costantini F.

Biochem Biophys Res Commun. 1999 Dec 9;266(1):28-35.

PMID:
10581160
5.

Wnt signaling controls the phosphorylation status of beta-catenin.

van Noort M, Meeldijk J, van der Zee R, Destree O, Clevers H.

J Biol Chem. 2002 May 17;277(20):17901-5. Epub 2002 Feb 7.

6.
7.

Protein kinase A negatively modulates the nuclear accumulation of NF-ATc1 by priming for subsequent phosphorylation by glycogen synthase kinase-3.

Sheridan CM, Heist EK, Beals CR, Crabtree GR, Gardner P.

J Biol Chem. 2002 Dec 13;277(50):48664-76. Epub 2002 Sep 25.

10.

Glycogen synthase kinase-3 interacts with and phosphorylates estrogen receptor alpha and is involved in the regulation of receptor activity.

Medunjanin S, Hermani A, De Servi B, Grisouard J, Rincke G, Mayer D.

J Biol Chem. 2005 Sep 23;280(38):33006-14. Epub 2005 Aug 1.

11.

Regulation of neuroprotective activity of myocyte-enhancer factor 2 by cAMP-protein kinase A signaling pathway in neuronal survival.

Wang X, Tang X, Li M, Marshall J, Mao Z.

J Biol Chem. 2005 Apr 29;280(17):16705-13. Epub 2005 Feb 25.

12.

Cyclic GMP-dependent protein kinase regulates CCAAT enhancer-binding protein beta functions through inhibition of glycogen synthase kinase-3.

Zhao X, Zhuang S, Chen Y, Boss GR, Pilz RB.

J Biol Chem. 2005 Sep 23;280(38):32683-92. Epub 2005 Jul 29.

13.

NDRG2 expression decreases with tumor stages and regulates TCF/beta-catenin signaling in human colon carcinoma.

Kim YJ, Yoon SY, Kim JT, Song EY, Lee HG, Son HJ, Kim SY, Cho D, Choi I, Kim JH, Kim JW.

Carcinogenesis. 2009 Apr;30(4):598-605. doi: 10.1093/carcin/bgp047. Epub 2009 Feb 23.

14.

A lentivirus-mediated genetic screen identifies dihydrofolate reductase (DHFR) as a modulator of beta-catenin/GSK3 signaling.

Klinghoffer RA, Frazier J, Annis J, Berndt JD, Roberts BS, Arthur WT, Lacson R, Zhang XD, Ferrer M, Moon RT, Cleary MA.

PLoS One. 2009 Sep 3;4(9):e6892. doi: 10.1371/journal.pone.0006892.

15.

A role for mixed lineage kinases in regulating transcription factor CCAAT/enhancer-binding protein-{beta}-dependent gene expression in response to interferon-{gamma}.

Roy SK, Shuman JD, Platanias LC, Shapiro PS, Reddy SP, Johnson PF, Kalvakolanu DV.

J Biol Chem. 2005 Jul 1;280(26):24462-71. Epub 2005 May 4.

16.

Nopp140 is a mediator of the protein kinase A signaling pathway that activates the acute phase response alpha1-acid glycoprotein gene.

Chiu CM, Tsay YG, Chang CJ, Lee SC.

J Biol Chem. 2002 Oct 18;277(42):39102-11. Epub 2002 Aug 7.

17.
18.
19.

Expression and characterization of GSK-3 mutants and their effect on beta-catenin phosphorylation in intact cells.

Hagen T, Di Daniel E, Culbert AA, Reith AD.

J Biol Chem. 2002 Jun 28;277(26):23330-5. Epub 2002 Apr 19.

20.

Supplemental Content

Support Center